1601628

11932

We have studied the three-dimensional structure of a biologically active peptide of apolipoprotein C-II (apoC-II) in the presence of lipid mimetics by CD and NMR spectroscopy. This peptide, corresponding to residues 44–79 of apoC-II, has been shown to reverse the symptoms of genetic apoC-II deficiency in a human subject. A comparison of α-proton secondary shifts and CD spectroscopic data indicates that the structure of apoC-II(44–79) is similar in the presence of dodecylphosphocholine and sodium dodecyl sulfate. The three-dimensional structure of apoC-II(44–79) in the presence of sodium dodecyl sulfate, determined by relaxation matrix calculations, contains two amphipathic helical domains formed by residues 50–58 and 67–75, separated by a non-helical linker centered at Tyr63. The C-terminal helix is terminated by a loop formed by residues 76–79. The C-terminal helix is better defined and has a larger hydrophobic face than the N-terminal helix, which leads us to propose that the C-terminal helix together with the non-helical Ile66 constitute the primary lipid binding domain of apoC-II(44–79). Based on our structure we suggest a new mechanism of lipoprotein lipase activation in which both helices of apoC-II(44–79) remain lipid bound, while the seven-residue interhelical linker extends away from the lipid surface in order to project Tyr63 into the apoC-II binding site of lipoprotein lipase.

253

Lipase activation , NMR , Relaxation matrix , Cd , VLDL , lipoprotein

Studia Iranica

264

264